Jefferies raised its year-end target for the S&P 500 index to 6,600, citing robust second-quarter corporate earnings, easing ...

Pricey prescriptions and nagging medical costs are swamping some insurers and employers, which means patients may start ...

(Reuters) -Jefferies lifted its year-end target for the S&P 500 index to 6,600, citing robust corporate earnings, easing ...

In a major development for primary market investors, the Indian multinational hospitality and technology company, OYO, is all ...

Illinois Gov. JB Pritzker has pushed back against Trump’s threat to send troops to Chicago, saying, “We don’t play those ...

The Personal Consumption Expenditures Price index - the U.S. Federal Reserve's preferred inflation gauge - is due to be ...

These are just a few quotes, but many on Wall Street seem to have the same thought. Financial information website MarketWatch ...

(Reuters) -Jefferies lifted its year-end target for the S&P 500 index to 6,600, highlighting robust corporate earnings as a ...

The report highlights that India's CRDMO industry has caught the attention of global investors, with its market ...

Wood, however, cautioned that India is an expensive market and has always traded at a premium compared with other emerging ...

Divi's Laboratories' custom synthesis segment has clocked strong year-on-year growth of 19% in the financial year 2025.

According to a recent Jefferies India report, the country's CRDMO, which has already reached revenues of around USD 3 billion ...